Cowealth Medical China Co.Ltd. (603122) — Cash Flow Reinvestment Rate
Cowealth Medical China Co.Ltd. (603122) has a Cash Flow Reinvestment Rate of 8.06x as of December 2025, reinvesting CN¥142.58 Million (capex CN¥14.21 Million plus investments CN¥-128.37 Million) from operating cash flow of CN¥17.68 Million. Check earnings quality score of Cowealth Medical China Co.Ltd. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cowealth Medical China Co.Ltd. Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Cowealth Medical China Co.Ltd. across 5 annual periods. Explore 603122 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Cowealth Medical China Co.Ltd. (2020–2025)
Year-by-year capital reinvestment analysis for Cowealth Medical China Co.Ltd.. For live market cap and broader valuation context, see 603122 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 8.06x | CN¥142.58 Million | CN¥17.68 Million | CN¥14.21 Million | ▲ +1663.2% |
| 2024 | 0.46x | CN¥60.72 Million | CN¥132.75 Million | CN¥31.82 Million | ▼ -93.5% |
| 2023 | 7.02x | CN¥79.21 Million | CN¥11.28 Million | CN¥67.96 Million | ▲ +24.5% |
| 2021 | 5.64x | CN¥39.55 Million | CN¥7.01 Million | CN¥22.12 Million | ▲ +181.0% |
| 2020 | 2.01x | CN¥148.85 Million | CN¥74.15 Million | CN¥8.11 Million | — |